Page 186 - 15Diarrhoeaandvomiting
P. 186

References




               145.  Robins-Browne RM, Mackenjee MK, Bodasing MN, et al. Treatment of Campylobacter-associated enteritis with erythromycin. American
                    Journal of Diseases of Children 1983;137:282–5.
               146.  Pai CH, Gillis F, Tuomanen E, et al. Erythromycin in treatment of Campylobacter enteritis in children. American Journal of Diseases of
                    Children 1983;137:286–8.
               147.  Salazar-Lindo E, Sack RB, Chea-Woo E, et al. Early treatment with erythromycin of Campylobacter jejuni-associated dysentery in children.
                    Journal of Pediatrics 1986;109:355–60.
               148.  Pai CH, Gillis F, Tuomanen E, et al. Placebo-controlled double-blind evaluation of trimethoprim-sulfamethoxazole treatment of Yersinia
                    enterocolitica gastroenteritis. Journal of Pediatrics 1984;104:308–11.
               149.  Amadi B, Mwiya M, Musuku J, et al. Effect of nitazoxanide on morbidity and mortality in Zambian children with cryptosporidiosis: a
                    randomised controlled trial. Lancet 2002;360:1375–80.
               150.  Abdel-Maboud AI, Rossignol JF, el-Kady MS, et al. Cryptosporidiosis in Benha, study of some recent modalities in diagnosis and treatment.
                    Journal of the Egyptian Society of Parasitology 2000;30:717–25.
               151.  Wolfsdorf J, Myer EC. Trimethoprim-sulphonamide mixture in the treatment of infantile gastro-enteritis.  South African Medical Journal
                    1973;47:1887–9.
               152.  Robins-Browne RM, Coovadia HM, Bodasing MN, et al. Treatment of acute nonspecific gastroenteritis of infants and young children with
                    erythromycin. American Journal of Tropical Medicine and Hygiene 1983;32:886–90.
               153.  Oberhelman RA, Javier de la CF, Vasquez GE, et al. Efficacy of trimethoprim-sulfamethoxazole in treatment of acute diarrhea in a Mexican
                    pediatric population. Journal of Pediatrics 1987;110:960–5.
               154.  Rodriguez  RS,  Chavez  AZ,  Galindo  E.  A  randomized,  controlled,  single-blind  study  comparing  furazolidone  with  trimethoprim-
                    sulfamethoxazole  in  the  empirical  treatment  of  acute  invasive  diarrhea.  Scandinavian  Journal  of  Gastroenterology  –  Supplement
                    1989;169:47–53.
               155.  De Bruyn G, Hahn S, Borwick A. Antibiotic treatment for travellers’ diarrhoea. Cochrane Database of Systematic Reviews 2000;(3):CD002242.
               156.  Wong CS, Jelacic S, Habeeb RL, et al. The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7
                    infections. New England Journal of Medicine 2000;342:1930–6.
               157.  Bell BP, Griffin PM, Lozano P, et al. Predictors of hemolytic uremic syndrome in children during a large outbreak of Escherichia coli
                    O157:H7 infections. Pediatrics 1997;100:E12.
               158.  Lee WS, Puthucheary SD, Boey CC. Non-typhoid Salmonella gastroenteritis. Journal of Paediatrics and Child Health 1998;34:387–90.
               159.  Nelson  EA,  Mok TC, Yu  LM.  Retrospective  comparison  of  management  of  gastro-enteritis  in  hospitalised  children.  Annals  of  Tropical
                    Paediatrics 2002;22:165–71.
               160.  Roslund G, Hepps TS, McQuillen KK. The role of oral ondansetron in children with vomiting as a result of acute gastritis/gastroenteritis who
                    have failed oral rehydration therapy: a randomized controlled trial. Annals of Emergency Medicine 2008;52:22–9.
               161.  Stork CM, Brown KM, Reilly TH, et al. Emergency department treatment of viral gastritis using intravenous ondansetron or dexamethasone
                    in children. Academic Emergency Medicine 2006;13:1027–33.
               162.  Joint Formulary Committee. British National Formulary. 54 ed. London: British Medical Association and Royal Pharmaceutical Society of
                    Great Britain; 2007.
               163.  Freedman SB, Adler M, Seshadri R, et al. Oral ondansetron for gastroenteritis in a pediatric emergency department. New England Journal of
                    Medicine 2006;354:1698–705.
               164.  Ramsook C, Sahagun-Carreon I, Kozinetz CA, et al. A randomized clinical trial comparing oral ondansetron with placebo in children with
                    vomiting from acute gastroenteritis. Annals of Emergency Medicine 2002;39:397–403.
               165.  Cubeddu  LX, Trujillo  LM, Talmaciu  I,  et  al. Antiemetic  activity  of  ondansetron  in  acute  gastroenteritis.  Alimentary  Pharmacology  and
                    Therapeutics 1997;11:185–91.
               166.  Watkinson M. A lack of therapeutic response to kaolin in acute childhood diarrhoea treated with glucose electrolyte solution. Journal of
                    Tropical Pediatrics 1982;28:306–7.
               167.  Sebodo T, Iman S, Sobiran H, et al. Carbo-adsorbent (Norit) in the treatment of children with diarrhoea. Southeast Asian Journal of Tropical
                    Medicine and Public Health 1982;13:424–6.
               168.  Szajewska H, Dziechciarz P, Mrukowicz J. Meta-analysis: Smectite in the treatment of acute infectious diarrhoea in children. Alimentary
                    Pharmacology and Therapeutics 2006;23:217–27.
               169.  Salazar-Lindo E, Santisteban-Ponce J, Chea-Woo E, et al. Racecadotril in the treatment of acute watery diarrhea in children. New England
                    Journal of Medicine 2000;343:463–7.
               170.  Cezard JP, Duhamel JF, Meyer M, et al. Efficacy and tolerability of racecadotril in acute diarrhea in children. Gastroenterology 2001;120:799–805.
               171.  Chowdhury HR, Yunus M, Zaman K, et al. The efficacy of bismuth subsalicylate in the treatment of acute diarrhoea and the prevention of
                    persistent diarrhoea. Acta Paediatrica 2001;90:605–10.
               172.  Figueroa-Quintanilla D, Salazar-Lindo E, Sack RB, et al. A controlled trial of bismuth subsalicylate in infants with acute watery diarrheal
                    disease. New England Journal of Medicine 1993;328:1653–8.
               173.  Soriano-Brucher H, Avendano P, O’Ryan M, et al. Bismuth subsalicylate in the treatment of acute diarrhea in children: a clinical study.
                    Pediatrics 1991;87:18–27.
               174.  Li ST, Grossman DC, Cummings P. Loperamide therapy for acute diarrhea in children: systematic review and meta-analysis. PLoS Medicine
                    2007;4:e98.
               175.  Brooks WA, Santosham M, Roy SK, et al. Efficacy of zinc in young infants with acute watery diarrhea. American Journal of Clinical Nutrition
                    2005;82:605–10.
               176.  Bahl R, Bhandari N, Saksena M, et al. Efficacy of zinc-fortified oral rehydration solution in 6- to 35-month-old children with acute diarrhea.
                    Journal of Pediatrics 2002;141:677–82.
               177.  Sazawal S, Black RE, Bhan MK, et al. Zinc supplementation in young children with acute diarrhea in India. New England Journal of Medicine
                    1995;333:839–44.
               178.  Yalcin SS, Yurdakok K, Tezcan I, et al. Effect of glutamine supplementation on diarrhea, interleukin-8 and secretory immunoglobulin A in
                    children with acute diarrhea. Journal of Pediatric Gastroenterology and Nutrition 2004;38:494–501.
               179.  Ashraf H, Rahman MM, Fuchs GJ, et al. Folic acid in the treatment of acute watery diarrhoea in children: a double-blind, randomized,
                    controlled trial. Acta Paediatrica 1998;87:1113–15.
               180.  Lazzerini M, Ronfani L. Oral zinc for treating diarrhoea in children. Cochrane Database of Systematic Reviews 2008;(3):CD005436.



                                                                                                         161
   181   182   183   184   185   186   187   188   189   190   191